UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Gene polymorphism of dopaminergic, serotoninergic and glutamatergic receptors and tardive dyskinesia in schizophrenia

European neuropsychopharmacology, 2016-10, Vol.26, p.S495-S496

2016

Volltextzugriff (PDF)

Association of PIP5K2A and SGK1 genes with drug-induced dyskinesia in patients with schizophrenia

European neuropsychopharmacology, 2016-10, Vol.26, p.S180-S181

2016

Volltextzugriff (PDF)

CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias

European neuropsychopharmacology, 2016-10, Vol.26, p.S656-S657

2016

Volltextzugriff (PDF)

Gene polymorphisms of cytochrome P450, 1A2, 2D6 and drug-induced tardive dyskinesia in Russian patients with schizophrenia

European neuropsychopharmacology, 2016-10, Vol.26, p.S512-S513

2016

Volltextzugriff (PDF)

Gene polymorphism of serotonin receptors and drug-induced hyperprolactinemia in schizophrenic patients

European neuropsychopharmacology, 2016-10, Vol.26, p.S515-S516

2016

Volltextzugriff (PDF)

P.3.a.006 Tardive dyskinesia, dehydroepiandrosterone sulfate and cytochrome P450c17α gene polymorphism in psychiatric inpatients

European neuropsychopharmacology, 2014-10, Vol.24, p.S486-S487

2014

Volltextzugriff (PDF)

P.3.005 Tardive dyskinesia and polymorphisms of the phosphatidylinositol-4-phosphate 5-kinase IIa gene in Russian schizophrenic patients

European neuropsychopharmacology, 2012-03, Vol.22, p.S56-S56

2012

Volltextzugriff (PDF)

P.3.a.014 - Gene polymorphism of dopaminergic, serotoninergic and glutamatergic receptors and tardive dyskinesia in schizophrenia

European neuropsychopharmacology, 2016-10, Vol.26, p.S495-S496

2016

Volltextzugriff (PDF)

P.3.c.017 Influence of atypical neuroleptic quetiapine on the serum dehydroepiandrosterone/ cortisol ratio in schizophrenia

European neuropsychopharmacology, 2007, Vol.17, p.S433-S434

2007

Volltextzugriff (PDF)

P.3.c.050 Interaction between polymorphisms of oxidative enzymes and susceptibility to tardive dyskinesia in psychiatric patients

European neuropsychopharmacology, 2010, Vol.20, p.S486-S487

2010

Volltextzugriff (PDF)

P.1.a.031 - Association of PIP5K2A and SGK1 genes with drug-induced dyskinesia in patients with schizophrenia

European neuropsychopharmacology, 2016-10, Vol.26, p.S180-S181

2016

Volltextzugriff (PDF)

P.3.b.032 - Gene polymorphisms of cytochrome P450, 1A2, 2D6 and drug-induced tardive dyskinesia in Russian patients with schizophrenia

European neuropsychopharmacology, 2016-10, Vol.26, p.S512-S513

2016

Volltextzugriff (PDF)

P.3.c.006 - Association of polymorphism in the dopamine receptors and transporter genes with hyperprolactinemia in patients with schizophrenia

European neuropsychopharmacology, 2017-10, Vol.27, p.S923-S924

2017

Volltextzugriff (PDF)

P.1.a.025 - Dopamine receptors genes polymorphisms in Parkinson patients with levodopa-induced dyskinesia

European neuropsychopharmacology, 2017-10, Vol.27, p.S590-S590

2017

Volltextzugriff (PDF)

Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson’s disease

European neuropsychopharmacology, 2017-10, Vol.27, p.S1039-S1040

2017

Volltextzugriff (PDF)

Dopamine receptors genes polymorphisms in Parkinson patients with levodopa-induced dyskinesia

European neuropsychopharmacology, 2017-10, Vol.27, p.S590

2017

Volltextzugriff (PDF)

P.5.d.009 - Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson’s disease

European neuropsychopharmacology, 2017-10, Vol.27, p.S1039-S1040

2017

Volltextzugriff (PDF)

Association of polymorphism in the dopamine receptors and transporter genes with hyperprolactinemia in patients with schizophrenia

European neuropsychopharmacology, 2017-10, Vol.27, p.S923-S924

2017

Volltextzugriff (PDF)

P.3.b.037 - Gene polymorphism of serotonin receptors and drug-induced hyperprolactinemia in schizophrenic patients

European neuropsychopharmacology, 2016-10, Vol.26, p.S515-S516

2016

Volltextzugriff (PDF)

P.5.d.005 - CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias

European neuropsychopharmacology, 2016-10, Vol.26, p.S656-S657

2016

Volltextzugriff (PDF)

P.3.d.043 - Association between P-glycoprotein polymorphisms and antipsychotic drug-induced hyperprolactinemia

European neuropsychopharmacology, 2017-10, Vol.27, p.S956-S956

2017

Volltextzugriff (PDF)

Association between P-glycoprotein polymorphisms and antipsychotic drug-induced hyperprolactinemia

European neuropsychopharmacology, 2017-10, Vol.27, p.S956

2017

Volltextzugriff (PDF)

P.5.d.005 Polymorphisms of DRD2, DRD3, DRD4 and HTR2C genes in levodopa-induced dyskinesias in Parkinson's disease

European neuropsychopharmacology, 2015-09, Vol.25, p.S589-S589

2015

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

Internal Medicine
(10)
Psychiatry
(10)

Kollektion

EZB-NALI5-00465 Elsevier Archive NL
(23)
IngentaConnect
(23)
Access via ScienceDirect (Elsevier)
(23)
IngentaConnect Journals
(7)

Zeitschrift / Serie

European Neuropsychopharmacology
(23)

Menü

Weitere Dienste

Einstellungen

Gene polymorphism of dopaminergic, serotoninergic and glutamatergic receptors and tardive dyskinesia in schizophrenia

Association of PIP5K2A and SGK1 genes with drug-induced dyskinesia in patients with schizophrenia

CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias

Gene polymorphisms of cytochrome P450, 1A2, 2D6 and drug-induced tardive dyskinesia in Russian patients with schizophrenia

Gene polymorphism of serotonin receptors and drug-induced hyperprolactinemia in schizophrenic patients

P.3.a.006 Tardive dyskinesia, dehydroepiandrosterone sulfate and cytochrome P450c17α gene polymorphism in psychiatric inpatients

P.3.005 Tardive dyskinesia and polymorphisms of the phosphatidylinositol-4-phosphate 5-kinase IIa gene in Russian schizophrenic patients

P.3.a.014 - Gene polymorphism of dopaminergic, serotoninergic and glutamatergic receptors and tardive dyskinesia in schizophrenia

P.3.c.017 Influence of atypical neuroleptic quetiapine on the serum dehydroepiandrosterone/ cortisol ratio in schizophrenia

P.3.c.050 Interaction between polymorphisms of oxidative enzymes and susceptibility to tardive dyskinesia in psychiatric patients

P.1.a.031 - Association of PIP5K2A and SGK1 genes with drug-induced dyskinesia in patients with schizophrenia

P.3.b.032 - Gene polymorphisms of cytochrome P450, 1A2, 2D6 and drug-induced tardive dyskinesia in Russian patients with schizophrenia

P.3.c.006 - Association of polymorphism in the dopamine receptors and transporter genes with hyperprolactinemia in patients with schizophrenia

P.1.a.025 - Dopamine receptors genes polymorphisms in Parkinson patients with levodopa-induced dyskinesia

Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson’s disease

Dopamine receptors genes polymorphisms in Parkinson patients with levodopa-induced dyskinesia

P.5.d.009 - Predictive genetic model for levodopa-induced dyskinesia in patients with Parkinson’s disease

Association of polymorphism in the dopamine receptors and transporter genes with hyperprolactinemia in patients with schizophrenia

P.3.b.037 - Gene polymorphism of serotonin receptors and drug-induced hyperprolactinemia in schizophrenic patients

P.5.d.005 - CYP2D6 and catechol-O-methyltransferase gene polymorphisms in Parkinson patients with levodopa-induced dyskinesias

P.3.d.043 - Association between P-glycoprotein polymorphisms and antipsychotic drug-induced hyperprolactinemia

Association between P-glycoprotein polymorphisms and antipsychotic drug-induced hyperprolactinemia

P.5.d.005 Polymorphisms of DRD2, DRD3, DRD4 and HTR2C genes in levodopa-induced dyskinesias in Parkinson's disease

Suchergebnisse filtern